Latest News of CVAC
CureVac NV (CVAC) Q3 2024 Earnings Call Highlights: Strong Financial Performance and Strategic ...
By Yahoo! Finance |
1 week ago
CureVac NV faces competition in the vaccine market and is focused on differentiating its mRNA technology. The company collaborates with GSK in oncology and infectious diseases, exploring new opportuni...
We Think CureVac (NASDAQ:CVAC) Can Afford To Drive Business Growth
By Yahoo! Finance |
3 months ago
Although a company's lack of profitability does not guarantee a stock decline, monitoring cash burn is crucial. For instance, CureVac (NASDAQ:CVAC) had €300m in cash reserves and a €312m cash burn...
An Intrinsic Calculation For CureVac N.V. (NASDAQ:CVAC) Suggests It's 47% Undervalued
By Yahoo! Finance |
4 months ago
The article discusses using the Discounted Cash Flow (DCF) model to estimate the intrinsic value of CureVac N.V. (NASDAQ:CVAC), indicating a higher analyst price target than the fair value estimate....